XBIO Xenetic Biosciences, Inc.
$1.82▲ +6.08%
Healthcare
Other
Volume 10.1K
Avg Volume (10D) 23.1K
Key Metrics & Fundamentals
Market Cap
$4.28M
P/E Ratio
–
Div Yield
0.00%
52W Range
1.58 - 4.94
% vs 50 MA
-37.59%
% vs 200 MA
-35.87%
RSI-14
33.5
MACD Histogram
+0.0200
Beta (1Y vs SPY)
1.56
Free Cash Flow
-$875,489
Gross Rev
$660,601
Gross Profit
$660,601
EBITDA
-$971,690
COGS
–
Operating Exp
$1.63M
Operating Income
-$971,690
EBIT
-$971,690
Pretax Income
-$929,695
Net Income
-$929,695
EPS (Diluted)
-0.41
Price & Volume History
Loading chart…
Recent News
Xenetic Biosciences and PeriNess Announce First Patient Dosed in Investigator-Initiated Study at Tel Aviv Sourasky University Medical Center Evaluating Systemic DNase in Combination with CAR T Cells for Large B-Cell Lymphoma
ACCESS Newswire · Oct 15, 2026 8:46 AM ET
Top Midday Decliners
MT Newswires · Sep 16, 2026 2:53 PM ET
Xenetic Biosciences Announces All-Stock Merger with Santersus, Leaving Existing Shareholders with 15% Stake
InvestorsHub · Sep 16, 2026 10:30 AM ET
Micro Cap Xenetic Biosciences Expands Therapeutic Platform With Santersus Acquisition
Benzinga · Sep 16, 2026 10:28 AM ET
Xenetic Biosciences and Santersus AG Announce Definitive Share Exchange Agreement to Create Global Leader in NET-Targeting Therapeutics
ACCESS Newswire · Sep 16, 2026 7:00 AM ET
Xenetic Biosciences Reports Second Quarter 2026 Financial Results and Highlights Strengthened Scientific Foundation Supporting Continued Advancement of Proprietary DNase Platform
ACCESS Newswire · Aug 7, 2026 8:35 AM ET
Xenetic Biosciences: Q2 Earnings Snapshot
Associated Press · Aug 7, 2026 3:32 AM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See XBIO's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.